We are live on
!
Find out more
SOADOR
State of Alaska Department of Revenue Portfolio holdings
AUM
$10.1B
1-Year Est. Return
42.83%
This Fund
S&P 500
This Quarter
Est. Return
+22.12%
1 Year Est. Return
+42.83%
3 Year Est. Return
+118.17%
5 Year Est. Return
+152.69%
10 Year Est. Return
+471.25%
AUM
$7.83B
AUM Growth
+$1.5B
(+24%)
Cap. Flow
+$261M
Cap. Flow
% of AUM
3.33%
Top 10 Holdings %
Top 10 Hldgs %
16.94%
Holding
1,668
New
40
Increased
1,120
Reduced
438
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$17.8M |
| 2 |
Amazon
AMZN
|
+$15.1M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$12.8M |
| 4 |
Merck
MRK
|
+$12.3M |
| 5 |
Walmart Inc
WMT
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$12.5M |
| 2 |
RTN
Raytheon Company
RTN
|
+$11.9M |
| 3 |
Broadcom
AVGO
|
+$7.97M |
| 4 |
TJX Companies
TJX
|
+$7.95M |
| 5 |
PPLI
People Inc
PPLI
|
+$7.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Healthcare | 13.95% |
| 3 | Financials | 12.83% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
West Pharmaceutical
WST
$24.5B
| $9.91M | 0.13% |
43,645
+26,658
| +157% | +$5.24M |
|
202
Mettler-Toledo International
MTD
$28.6B
| $9.89M | 0.13% |
12,277
+1,843
| +18% | +$1.37M |
|
203
Incyte
INCY
$24.3B
| $9.81M | 0.13% |
94,335
+63,590
| +207% | +$6.13M |
|
|
FISV
204
Fiserv Inc
FISV
$28.7B
| $9.77M | 0.12% |
100,074
-64,657
| -39% | -$6.51M |
|
205
Emerson Electric
EMR
$90.9B
| $9.73M | 0.12% |
156,878
+6,440
| +4% | +$366K |
|
206
ResMed
RMD
$32.8B
| $9.72M | 0.12% |
50,609
-6,526
| -11% | -$1.07M |
|
207
EOG Resources
EOG
$74.2B
| $9.69M | 0.12% |
191,358
+52,788
| +38% | +$2.56M |
|
208
DuPont de Nemours
DD
$19.4B
| $9.69M | 0.12% |
145,247
+9,748
| +7% | +$569K |
|
209
Illumina
ILMN
$28.9B
| $9.68M | 0.12% |
26,872
+850
| +3% | +$274K |
|
210
Qorvo
QRVO
$8.68B
| $9.66M | 0.12% |
87,409
-15,399
| -15% | -$1.53M |
|
211
Simon Property Group
SPG
$71.8B
| $9.63M | 0.12% |
140,859
+285
| +0.2% | +$17.9K |
|
212
KLA
KLAC
$276B
| $9.63M | 0.12% |
495,030
-295,540
| -37% | -$5.05M |
|
213
Edwards Lifesciences
EW
$53.5B
| $9.61M | 0.12% |
139,014
-18,345
| -12% | -$1.3M |
|
214
Northern Trust
NTRS
$34.8B
| $9.59M | 0.12% |
120,869
+84,383
| +231% | +$6.69M |
|
215
MSCI
MSCI
$41.2B
| $9.56M | 0.12% |
28,656
-12,532
| -30% | -$4.05M |
|
216
Atmos Energy
ATO
$28.7B
| $9.49M | 0.12% |
95,306
+1,210
| +1% | +$122K |
|
217
Travelers Companies
TRV
$77.2B
| $9.39M | 0.12% |
82,375
+10,674
| +15% | +$1.12M |
|
|
PXD
218
DELISTED
Pioneer Natural Resource Co.
PXD
| $9.37M | 0.12% |
95,862
+67,348
| +236% | +$5.94M |
|
219
Kinder Morgan
KMI
$71.7B
| $9.35M | 0.12% |
616,389
-30,934
| -5% | -$470K |
|
220
Idexx Laboratories
IDXX
$44.3B
| $9.34M | 0.12% |
28,292
-11,613
| -29% | -$3.36M |
|
221
Weyerhaeuser
WY
$17.9B
| $9.33M | 0.12% |
415,596
+30,236
| +8% | +$612K |
|
222
Autodesk
ADSK
$53B
| $9.33M | 0.12% |
38,993
+1,076
| +3% | +$212K |
|
|
GRMN
223
Garmin
GRMN
$60.4B
| $9.22M | 0.12% |
94,601
+69,728
| +280% | +$5.96M |
|
224
Invitation Homes
INVH
$18B
| $9.18M | 0.12% |
333,533
+180,984
| +119% | +$4.54M |
|
225
Global Payments
GPN
$24.4B
| $9.14M | 0.12% |
53,893
+2,111
| +4% | +$351K |
|
Similar funds
RI
RA
HRCM
ACA
HI
MF
MPI
URS
State of Alaska Department of Revenue's Q2 2020 Portfolio in Review
As of Q2 2020, State of Alaska Department of Revenue held 1,668 positions worth $7.83B, up 24% from $6.33B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
State of Alaska Department of Revenue deployed $261M of net new capital in Q2 2020, opening 40 new positions and adding to 1,120 existing holdings. Its largest new stake was Seagen Inc. Common Stock: 60,853 shares worth $10.3M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Broadcom, an estimated $7.97M trimmed.
- State of Alaska Department of Revenue's largest Q2 2020 buy was Seagen Inc. Common Stock: 60,853 shares worth $10.3M.
- State of Alaska Department of Revenue added most to Gilead Sciences in Q2 2020, an estimated $17.8M increase.
- State of Alaska Department of Revenue's biggest Q2 2020 reduction was Broadcom, cutting an estimated $7.97M.
- State of Alaska Department of Revenue fully exited Allergan plc in Q2 2020, selling an estimated $12.5M.
- State of Alaska Department of Revenue's ten largest holdings make up 17% of its $7.83B portfolio in Q2 2020.
- State of Alaska Department of Revenue opened 40 new positions and closed 36 in Q2 2020.
- State of Alaska Department of Revenue's portfolio value rose 24% quarter-over-quarter to $7.83B.
Based on State of Alaska Department of Revenue's 13F filing for Q2 2020, filed 6 Jul 2020.